250 related articles for article (PubMed ID: 16111536)
1. Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
Au WY; Lam CC; Chim CS; Pang AW; Kwong YL
Leuk Res; 2005 Oct; 29(10):1213-5. PubMed ID: 16111536
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H).
Ru X; Liebman HA
Br J Haematol; 2003 Oct; 123(2):278-81. PubMed ID: 14531909
[TBL] [Abstract][Full Text] [Related]
3. Remission of pure red cell aplasia in T-cell receptor gammadelta-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab.
Schützinger C; Gaiger A; Thalhammer R; Vesely M; Fritsche-Polanz R; Schwarzinger I; Ohler L; Simonitsch-Klupp I; Reinhard F; Jäger U
Leukemia; 2005 Nov; 19(11):2005-8. PubMed ID: 16193089
[No Abstract] [Full Text] [Related]
4. T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years.
Aribi A; Huh Y; Keating M; O'brien S; Ferrajoli A; Faderl S; Wierda W; Kantarjian H; Ravandi F
Leuk Res; 2007 Jul; 31(7):939-45. PubMed ID: 17045649
[TBL] [Abstract][Full Text] [Related]
5. [T-cell large granular lymphocytic leukemia associated with pure red cell aplasia, successfully treated with cyclophosphamide].
Mátrai Z; Lelkes G; Milosevits J; Páldiné HP; Pecze K
Orv Hetil; 1997 Aug; 138(33):2075-80. PubMed ID: 9304100
[TBL] [Abstract][Full Text] [Related]
6. Alemtuzumab for B-cell chronic lymphocytic leukemia.
Robak T
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1033-51. PubMed ID: 18588450
[TBL] [Abstract][Full Text] [Related]
7. Refractory idiopathic pure red cell aplasia complicated by immune thrombocytopenia successfully treated with subcutaneous alemtuzumab.
Pham DC; Guthrie TH; Villas BH; Salazar E
Am J Hematol; 2008 Jul; 83(7):603. PubMed ID: 18273896
[No Abstract] [Full Text] [Related]
8. Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment.
Monjanel H; Hourioux C; Arbion F; Colombat P; Lissandre S; Regner MP; Senecal D
Leuk Res; 2010 Aug; 34(8):e197-9. PubMed ID: 20211489
[No Abstract] [Full Text] [Related]
9. The role of alemtuzumab in the management of T-cell malignancies.
Dearden C
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S44-52. PubMed ID: 16720203
[TBL] [Abstract][Full Text] [Related]
10. CD52 expression in T-cell large granular lymphocyte leukemia--implications for treatment with alemtuzumab.
Osuji N; Del Giudice I; Matutes E; Morilla A; Owusu-Ankomah K; Morilla R; Dunlop A; Catovksy D
Leuk Lymphoma; 2005 May; 46(5):723-7. PubMed ID: 16019510
[TBL] [Abstract][Full Text] [Related]
11. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
[TBL] [Abstract][Full Text] [Related]
12. Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
Go RS; Li CY; Tefferi A; Phyliky RL
Blood; 2001 Jul; 98(2):483-5. PubMed ID: 11435321
[TBL] [Abstract][Full Text] [Related]
13. [A case of pure red cell aplasia accompanied with granular lymphocytic leukemia the tumor cells of which suppressed colony formation of BFU-E, and which was successfully treated by cyclophosphamide and cyclosporin A].
Hirayama Y; Nagai T; Ohta H; Koyama R; Matsunaga T; Sakamaki S; Niitsu Y
Rinsho Ketsueki; 1997 Nov; 38(11):1206-11. PubMed ID: 9423339
[TBL] [Abstract][Full Text] [Related]
14. Acquired pure red cell aplasia: updated review of treatment.
Sawada K; Fujishima N; Hirokawa M
Br J Haematol; 2008 Aug; 142(4):505-14. PubMed ID: 18510682
[TBL] [Abstract][Full Text] [Related]
15. Distinct effect of cyclophosphamide and cyclosporine on pure red cell aplasia associated with T-cell large granular lymphocyte leukemia.
Tabata R; Tabata C
Int Immunopharmacol; 2014 Dec; 23(2):391-4. PubMed ID: 25466263
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology and treatment of large granular lymphocyte leukemia-associated pure red cell aplasia].
Fujishima N
Rinsho Ketsueki; 2010 Aug; 51(8):589-96. PubMed ID: 20805663
[No Abstract] [Full Text] [Related]
17. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia.
Hohwy T; Bang K; Steiniche T; Peterslund NA; d'Amore F
Eur J Haematol; 2004 Sep; 73(3):206-9. PubMed ID: 15287918
[TBL] [Abstract][Full Text] [Related]
18. Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.
Montillo M; Tedeschi A; Miqueleiz S; Veronese S; Cairoli R; Intropido L; Ricci F; Colosimo A; Scarpati B; Montagna M; Nichelatti M; Regazzi M; Morra E
J Clin Oncol; 2006 May; 24(15):2337-42. PubMed ID: 16618945
[TBL] [Abstract][Full Text] [Related]
19. Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.
Hopfinger G; Busch R; Pflug N; Weit N; Westermann A; Fink AM; Cramer P; Reinart N; Winkler D; Fingerle-Rowson G; Stilgenbauer S; Döhner H; Kandler G; Eichhorst B; Hallek M; Herling M
Cancer; 2013 Jun; 119(12):2258-67. PubMed ID: 23512246
[TBL] [Abstract][Full Text] [Related]
20. Campath-1H induced pure red cell aplasia in a patient with chronic lymphatic leukaemia.
Thachil J; Salim R
Leuk Res; 2007 Jul; 31(7):1025-6. PubMed ID: 17005249
[No Abstract] [Full Text] [Related]
[Next] [New Search]